Managing Microbial Risk – A Quality by Design Approach
Posted on January 26, 2021
Linda Skowronsky, Senior Development Microbiologist,
GSK
Introduction According to World Health Organization, good pharmaceutical quality represents “an acceptably low risk of failing to achieve good clinical results”1; in other words, low risk of harm to the user. For a microbiologist, managing microbial quality can be an overwhelming task due to th...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















